Abstract
Ectopic expression of a truncated growth hormone–releasing hormone (GHRH) from muscle tissues by a myogenic plasmid DNA vector directed by the skeletal α-actin promoter, pSK-GHRH, results in growth hormone (GH) secretion. Skeletal muscle-secreted GHRH is biologically active. The application of conditioned media harvested from pSK-GHRH transfected muscle cells to cultured pig primary anterior pituitary cells elicits GH release. A single intramuscular injection of 100 μg pSK-GHRH DNA elevates serum GH levels threefold to fourfold for up to 2 weeks, enhancing liver IGF-1 gene expression and increasing body weight approximately 10%.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scanlon, M.F., Issa, B.G., and Dieguez, C. 1996. Regulation of growth hormone secretion. Horm. Res. 46: 149–154.
Enright, W.J., Prendiville, D.J., Spicer, L.J., Strieker, P.R., Moloney, A.P., Mowles, T.F., and Campbell, R.M. 1993. Effects of growth hormone-releasing factor and(or) thyrotropin-releasing hormone on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifers. J. Anim. Sci. 71: 2395–2405.
Enright, W.J., Chapin, L.T., Moseley, W.M., Zinn, S.A., and Tucker, H.A. 1986. Growth hormone-releasing factor stimulates milk production and sustains growth hormone release in Holstein cows. J. Dairy Sci. 69: 344–351.
LeRoith, D., Yanowski, J., Kaldjian, E.P., Jaffe, E.S., LeRoith, T., Purdue, K., et al. 1996. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 137: 1071–1079.
Kotzmann, H., Koller, M., Czernin, S., Clodi, M., Svoboda, T., Riedl, M., et al. 1994. Effect of elevated growth hormone concentrations on the phenotype and functions of human lymphocytes and natural killer cells. Neuroendocrinology 60: 618–625.
Iranmanesh, A., Lizarralde, G., and Veldhuis, J.D. 1991. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J. clin. Endocrinol. Metab. 73: 1081–1038.
D'Costa, A.P., Ingram, R.L., Lenham, J.E., and Sonntag, W.E. 1993. The regulation and mechanisms of action of growth hormone and insulin-like growth factor 1 during normal ageing. J. Reprod. Fertil. Suppl. 46: 87–98.
Corpas, E., Harman, S.M., and Blackman, M.R. 1993. Human growth hormone and human aging. Endocr. Rev. 14: 20–39.
Marcus, R., Butterfield, G., Holloway, L., Gilliland, L., Baylink, D.J., Hintz, R.L., and Sherman, B.M. 1990. Effects of short term administration of recombinant human growth hormone to elderly people. J. Clin. Endocrinol. Metab. 70: 519–527.
Salomon, F., Cuneo, R.C., Hesp, R., and Sonksen, P.H. 1989. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N. Engl. J. Med. 321: 1797–803.
Corpas, E., Harman, S.M., Pineyro, M.A., Roberson, R., and Blackman, M.R. 1993. Continuous subcutaneous infusions of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-l levels in old men. J. Clin. Endocrinol. Metab. 76: 134–138.
Mayo, K.E., Cerelli, G.M., Lebo, R.V., Bruce, B.D., Rosenfeld, M.G., and Evans, R.M. 1985. Gene encoding human growth hormone-releasing factor precursor: structure, sequence, and chromosomal assignment. Proc. Natl. Acad. Sci. USA 82: 63–67.
Mayo, K.E., Vale, W., Rivier, J., Rosenfeld, M.G., and Evans, R.M. 1983. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor. Nature 306: 86–88.
Riddell, D.C., Mallonee, R., Phillips, J.A., Parks, J.S., Sexton, L.A., and Hamerton, J.L. 1985. Chromosomal assignment of human sequences encoding arginine vasopressin-neurophysin II and growth hormone releasing factor. Som. Cell Mol. Genet. 11: 189–195.
Esch, F.S., Bohlen, P., Ling, N.C., Brazeau, P.E., Wehrenberg, W.B., Thorner, M.O., et al. 1982. Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity. Biochem. Biophys. Res. Comm. 109: 152–158.
Thorner, M.O., Frohman, L.A., Leong, D.A., Thominet, J., Downs, T., Hellmann, P., et al. 1984. Extrahypothalamic growth-hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J. Clin. Endocrinol. Metab. 59: 846–849.
Wolff, J.A., Ludtke, J.J., Acsadi, G., Williams, P., and Jani, A. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1: 363–369.
Wolff, J.A., Malone, R.W., Williams, P., Chong, W., Acsadi, G., Jani, A., and Feigner, P.L. 1990. Direct gene transfer into mouse muscle in vivo. Science 247: 1465–1468.
Davis, H.L., Whalen, R.G., and Demeneix, B.A. 1993. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 4: 151–159.
Wells, D.J. 1993. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 332: 179–182.
Bergsma, D.J., Grichnik, J.M., Gossett, L.M., and Schwartz, R.J. 1986. Delimitation and characterization of cis-acting DNA sequences required for the regulated expression and transcriptional control of the chicken skeletal alpha-act in gene. Mol. Cell. Biol. 6: 2462–2475.
Chow, K.L., and Schwartz, R.J. 1990. A combination of closely associated positive and negative cis-acting promoter elements regulates transcription of the skeletal alpha-actin gene. Mol. Ceil. Biol. 10: 528–538.
Lee, T.C., Zhang, Y., and Schwartz, R.J. 1994. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene 9: 1047–1052.
Ling, N., Baird, A., Wehrenberg, W.B., Ueno, N., Munegumi, T., and Brazeau, P. 1984. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. Biochem. Biophys. Res. Comm. 123: 854–861.
Bertherat, J., Bluet-Pajot, M.T., and Epelbaum, J. 1995. Neuroendocrine regulation of growth hormone. Eur. J. Endocrinol. 132: 12–24.
Low, L.C. 1993. The therapeutic use of growth-hormone-releasing hormone. J. Pediatr. Endocrinol. 6: 15–20.
Yao, S.N., Smith, K.J., and Kurachi, K. 1994. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Gene Therapy 1: 99–107.
Tripathy, S.K., Svensson, E.C., Black, H.B., Goldwasser, E., Margalith, M., Hobart, P.M., and Leiden, J.M. 1996. Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. Natl. Acad. Sci. USA 93: 10876–10880.
Tripathy, S.K., Black, H.B., Goldwasser, E., and Leiden, J.M. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Medicine 2: 545–550.
Levy, M.Y., Barron, L.G., Meyer, K.B., and Szoka, F.C. Jr. 1996. Characterization of plasmid DNA transfer into mouse skeletal muscle: evaluation of uptake mechanism, expression and secretion of gene products into blood. Gene Therapy 3: 201–211.
Cao, Y., Wagner, J.K., Hindmarsh, P.C., Eble, A., and Mullis, P.E. 1995. Isolated growth hormone deficiency: testing the little mouse hypothesis in man and exclusion of mutations within the extracellular domain of the growth hormone-releasing hormone receptor. Pediatr. Res. 38: 962–926.
Cogan, J.D., Phillips, J.A. 3d, Sakati, N., Frisch, H., Schober, E., and Milner, R.D. 1993. Heterogeneous growth hormone (GH) gene mutations in familial GH deficiency. J. Clin. Endocrinol. Metab. 76: 1224–1228.
Vnencak-Jones, C.L., Phillips, J.A. 3d, Chen, E.Y., and Seeburg, P.H. 1988. Molecular basis of human growth hormone gene deletions. Proc. Natl. Acad. Sci. USA 85: 5615–5619.
Amselem, S., Duquesnoy, P., Duriez, B., Dastot, F., Sobrier, M.L., Valleix, S., and Goossens, M. 1993. Spectrum of growth hormone receptor mutations and associated haplotypes in Laron syndrome. Hum. Mol. Genet. 2: 355–359.
Amselem, S., Duquesnoy, P., Sobrier, M.L., and Goossens, M. 1991. Molecular defects in the growth hormone receptor. A. Paediatr. Scandinavica Suppl. 377: 81–86.
Meacham, L.R., Brown, M.R., Murphy, T.L., Keret, R., Silbergeld, A., Laron, Z., and Parks, J.S. 1993. Characterization of a noncontiguous gene deletion of the growth hormone receptor in Laron's syndrome. J. Clin. Endocrinol. Metab. 77: 1379–1383.
Parks, J.S., Abdul-Latif, H., Kinoshita, E., Meacham, L.R., Pfaffle, R.W., and Brown, M.R. 1993. Genetics of growth hormone gene expression. Hormone Res. 40: 54–61.
Parks, J.S., Pfaffle, R.W., Brown, M.R., Abdul-Latif, H., and Meacham, L.R. 1995. Growth hormone deficiency, pp. 473–90 in Molecular endocrinology: basic concepts and clinical correlations. Weintraub, B.D. (ed.) Raven Press, New York.
Wang, Y., DeMayo, F.J., Tsai, S.Y., and O'Malley, B.W. 1997. Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology 15: 239–243.
Chow, K.L., Hogan, M.E., and Schwartz, R.J. 1991. Phased cis-acting promoter elements interact at short distances to direct avian skeletal alpha-actin gene transcription. Proc. Natl. Acad. Sci. USA 88: 1301–1305.
French, B.A., Bergsma, D.J., and Schwartz, R.J. 1990. Analysis of a CR1 (chicken repeat) sequence flanking the 5′ end of the gene encoding alpha-skeletal actin. Gene 88: 173–80.
Doumit, M.E. and Merkel, R.A. 1992. Conditions for isolation and culture of porcine myogenic satellite cells. Tissue & Cell 24: 253–262.
Tanner, J.W., Davis, S.K., McArthur, N.H., French, J.T., and Welsh, T.H., Jr. 1990. Modulation of growth hormone (GH) secretion and GH mRNA levels by GH-releasing factor, somatostatin and secretagogues in cultured bovine adenohy-pophysial cells. J. Endocrinol. 125: 109–115.
Barb, C.R., Estienne, M.J., Kraeling, R.R., Marple, D.N., Rampacek, G.B., Rahe, C.H., and Sartin, J.L. 1991. Endocrine changes in sows exposed to elevated ambient temperature during lactation. Domest. Anim. Endocrinol. 8: 117–127.
Danko, I., Fritz, J.D., Jiao, S., Hogan, K., Latendresse, J.S., and Wolff, J.A. 1994. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Therapy 1: 114–121.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Draghia-Akli, R., Li, X. & Schwartz, R. Enhanced growth by ectopic expression of growth hormone releasing hormone using an injectable myogenic vector. Nat Biotechnol 15, 1285–1289 (1997). https://doi.org/10.1038/nbt1197-1285
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt1197-1285
This article is cited by
-
Double-blinded, Placebo-controlled Plasmid GHRH Trial for Cancer-associated Anemia in Dogs
Molecular Therapy (2008)
-
Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences
Nature Biotechnology (1999)
-
Electropermeabilization of skeletal muscle enhances gene transfer in vivo
Gene Therapy (1999)
-
Myogenic expression of an injectable protease-resistant growth hormone–releasing hormone augments long-term growth in pigs
Nature Biotechnology (1999)
-
Growth hormone technology develops new twist
Nature Biotechnology (1997)